Orlando drug startup Enveda Therapeutics lands big investment

Orlando-based firm Enveda Therapeutics Inc. has raised $4.9 million, according to an Aug. 24 filing with the U.S. Securities and Exchange Commission. 

Enveda, launched in 2019, is in the process of building an “integrated dataset of anthropological, biological and chemical information from medicinal plants” to discover new medications, according to the company’s website. Read more here